New early prophylaxis regimen that avoids immunological danger signals can reduce FVIII inhibitor development
Authors:
- 25 February 2010
- journal article
- research article
- Published by Wiley in Haemophilia
- Vol. 16 (2) , 256-262
Abstract
Summary. The most problematic complication of haemophilia A treatment is the development of inhibitors to FVIII. The highest risk of developing inhibitors is during the first 20 exposure days (EDs). If the patient can be brought through this high risk period without inhibitor development, the subsequent risk is low. Therefore, as a pilot project, we developed a prophylaxis regimen for the first 20–50 EDs specifically designed to induce tolerance to the administered FVIII and to minimize inhibitor development by avoiding immunological danger signals. Twenty‐six consecutive previously untreated patients (PUPs) with severe haemophilia A were treated with the new prophylaxis regimen and the incidence of inhibitor development in this group was compared with that in a historical control group of 30 consecutive PUPs treated with a standard joint protection prophylaxis regimen (40–50 IU kg−1, three times a week). There were no significant differences between the study and control groups in patient‐related inhibitor risk factors such as ethnicity (all Caucasian), severity of haemophilia (all P < 0.0006) nor in some treatment‐related factors such as product type, age at first exposure, vaccination regimen or the need for surgery. 14 of 30 subjects given standard prophylaxis but only one of the 26 subjects given the new regimen developed an inhibitor (P = 0.0003, odds ratio 0.048, 95% CI: 0.001–0.372). Our results indicate that minimizing danger signals during the first 20 EDs with FVIII may reduce the risk of inhibitor formation. These results should be confirmed in a larger prospective clinical study.Keywords
This publication has 19 references indexed in Scilit:
- Inhibitor DevelopmentHaemophilia, 2008
- Early events in the recognition of danger signals after tissue injuryJournal of Leukocyte Biology, 2007
- The grateful dead: damage‐associated molecular pattern molecules and reduction/oxidation regulate immunityImmunological Reviews, 2007
- Genetic risk factors for inhibitors to factors VIII and IXHaemophilia, 2006
- DAMPs, PAMPs and alarmins: all we need to know about dangerJournal of Leukocyte Biology, 2006
- Inhibitor Development in Hemophiliacs: The Roles of Genetic versus Environmental FactorsSeminars in Thrombosis and Hemostasis, 2006
- The why and how of thymocyte negative selectionCurrent Opinion in Immunology, 2006
- Negative selection — clearing out the bad apples from the T-cell repertoireNature Reviews Immunology, 2003
- A Modification of Jerne's Theory of Antibody Production using the Concept of Clonal SelectionCA: A Cancer Journal for Clinicians, 1976
- A Theory of Self-Nonself DiscriminationScience, 1970